UFPTUFP TECHNOLOGIES INCvs its industry peers
A metric-by-metric comparison of UFP TECHNOLOGIES INC against Surgical & Medical Instruments & Apparatus — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UFPTEsta | $2.1B#8 | 29.8x#4 | 4.6x#7 | 3.5x#9 | 19.5%#5 | 15.8%#8 | 15.3%#2 | 14.8%#2 | 13.4%#1 | 7#1 | 34.1%#6 | — |
| MMSI | $5.1B#1 | 35.2x#5 | 3.0x#5 | 3.4x#8 | 11.8%#10 | 6.8%#10 | 12.2%#3 | 7.6%#4 | 7.1%#3 | 7#1 | 3.6%#9 | — |
| HAE | $4.9B#2 | 52.0x#6 | 5.9x#10 | 3.7x#10 | -2.0%#14 | -42.0%#14 | 11.7%#4 | 0.0%#7 | 6.7%#4 | 7#1 | 115.7%#2 | — |
| HTFL | $4.3B#3 | 16.6x#2 | 15.4x#13 | 24.5x#15 | 39.9%#2 | -21.1%#12 | -36.4%#14 | -41.8%#11 | — | — | 56.7%#4 | — |
| ICUI | $3.8B#4 | 128.5x#7 | 1.8x#2 | 1.7x#3 | -6.3%#15 | 100.6%#3 | 1.9%#7 | 0.0%#6 | 0.3%#6 | 6#6 | 18.9%#8 | — |
| IRTC | $3.7B#5 | — | 19.8x#14 | 4.9x#11 | 26.2%#3 | 60.2%#5 | -7.7%#9 | -24.2%#9 | — | 6#6 | -35.1%#15 | — |
| PLSE | $3.6B#6 | — | 36.3x#15 | 10311.2x#16 | — | -35.8%#13 | -21982.6%#16 | -73.1%#14 | — | — | 210.6%#1 | — |
| ATRC | $3.0B#7 | 281.3x#8 | 5.8x#9 | 5.6x#12 | 14.9%#6 | 74.4%#4 | -1.8%#8 | -2.2%#8 | -2.3%#7 | 7#1 | 68.6%#3 | — |
| INSP | $2.1B#9 | 16.1x#1 | 2.5x#3 | 2.3x#5 | 13.6%#7 | 171.8%#2 | 5.6%#6 | 17.6%#1 | 7.1%#2 | 7#1 | -9.1%#12 | — |
| NVCR | $1.9B#10 | — | 5.8x#8 | 3.0x#7 | 8.3%#11 | 19.4%#7 | -23.5%#12 | -40.3%#10 | -35.0%#11 | 3#12 | 31.8%#7 | — |
| LMAT | $1.8B#11 | 27.9x#3 | 4.3x#6 | 7.3x#13 | 13.5%#9 | 31.1%#6 | 27.2%#1 | 13.7%#3 | — | — | -12.6%#13 | 1.0%#1 |
| ATEC | $1.6B#12 | — | — | 2.1x#4 | 25.0%#4 | 11.6%#9 | -10.7%#10 | — | -18.5%#8 | 6#6 | -30.0%#14 | — |
| KMTS | $1.4B#13 | — | 6.5x#11 | 15.2x#14 | 59.0%#1 | -15.6%#11 | -141.6%#15 | -59.2%#13 | -59.5%#12 | 4#11 | 2.9%#10 | — |
| TNDM | $1.2B#14 | — | 9.2x#12 | 1.2x#2 | 7.9%#12 | -113.2%#15 | -18.5%#11 | -157.0%#15 | -26.3%#9 | 3#12 | 41.3%#5 | — |
| IART | $1.2B#15 | — | 1.1x#1 | 0.7x#1 | 1.5%#13 | -7389.9%#16 | -30.2%#13 | -49.5%#12 | -32.1%#10 | 6#6 | 2.0%#11 | — |
| AORT | $1.2B#16 | — | 2.6x#4 | 2.6x#6 | 13.6%#8 | 173.1%#1 | 7.6%#5 | 2.2%#5 | 3.0%#5 | 5#10 | -40.2%#16 | 0.3%#2 |
Peer set: US filers sharing this company's SEC industry classification (SIC 3841). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Table built 2026-09-18.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice